Sarepta Therapeutics, Inc. (SRPT)
16.84
-0.17
(-1.00%)
USD |
NASDAQ |
May 19, 12:30
Sarepta Therapeutics Market Cap : 1.778B for May 19, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| PTC Therapeutics, Inc. | 5.833B |
| Keros Therapeutics, Inc. | 199.90M |
| REGENXBIO, Inc. | 290.02M |
| Alnylam Pharmaceuticals, Inc. | 39.06B |
| Cytokinetics, Inc. | 10.32B |
Market Cap Related Metrics
| PS Ratio | 0.8357 |
| Price to Book Value | 1.181 |
| Price to Free Cash Flow | 20.02 |
| Price | 16.84 |
| Earnings Yield | -5.73% |
| Operating PE Ratio | 1743.39 |